SCHEMBL4856384

SCHEMBL4856384

CCOC(=O)C(C)(C)Oc1ccc(NC(=O)Cn2c(CC)nc(-c3ccccc3)cc2=O)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KAT2B Q92831 4/20 0.45
TP53 P04637 3/20 0.44
LMNA P02545 5/20 0.44
MAPT P10636 5/20 0.43
KDM4E B2RXH2 3/20 0.43
MEN1 O00255 3/20 0.43
ALDH1A1 P00352 3/20 0.43
KMT2A Q03164 3/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 1/20 0.41
POLB P06746 1/20 0.40
PPARA Q07869 3/20 0.40
CNR1 P21554 1/20 0.40
THRB P10828 1/20 0.40
TSHR P16473 2/20 0.40
ABCB11 O95342 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
HTR2A P28223 1/20 0.40
PMP22 Q01453 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4852487 0.91 KAT2B (0.47) KAT2BTP53LMNAMAPTKDM4E
SCHEMBL4861486 0.83 PPARA (0.44) PPARATSHRABCB11CYP1A2CYP3A4
SCHEMBL4851283 0.81 PPARA (0.42) TP53MAPTMEN1ALDH1A1KMT2A
SCHEMBL4855575 0.79 TP53 (0.44) KAT2BTP53LMNAMAPTKDM4E
SCHEMBL14263880 0.79 TP53 (0.42) KAT2BTP53LMNAMAPTKDM4E
SCHEMBL14263926 0.78 LMNA (0.43) KAT2BTP53LMNAMAPTKDM4E
SCHEMBL4859201 0.76 HTT (0.56) KDM4EMEN1ALDH1A1KMT2ATSHR
SCHEMBL4850624 0.76 PPARA (0.41) TP53LMNAMAPTKDM4EALDH1A1
SCHEMBL4850899 0.75 TLR7 (0.41) PPARAPPARG
SCHEMBL7699196 0.75 P2RY12 (0.38) PPARAPPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US claimed
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LTD. 2003-01-16 US claimed
US-7348334-B2 Monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them DR. REDDY'S LABORATORIES LIMITED (IN) 2008-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030013729-A1 New monocyclic derivatives of aryl alkanoic acids and their use in medicine: process for their preparation and pharmaceutical compositions containing them GPR119, FFAR1, FFAR3 KAT2B 2039/4885TP53 4510/4885LMNA 1699/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.